RecruitingPhase 3NCT03925701
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Clinical Study Evaluating the Effectiveness of Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Sponsor
Sherief Abd-Elsalam
Enrollment
120 participants
Start Date
Apr 1, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- NAFLD and type 2 DM
Exclusion Criteria3
- Viral hepatitis.
- Child score more than 6.
- renal impairment.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGVildagliptin
vildagliptin twice daily
DRUGvildagliptin\metformin
vildagliptin\\metformin twice daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03925701